卵圓孔未閉與慢性阻塞性肺疾病患者缺氧_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

 何權瀛

北京大學人民醫院呼吸科（北京 100049）;

Corresponding?author：

何權瀛, Email: hxk313@126.com

Keywords：

DOI：

10.7507/1671-6205.202204068

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 何權瀛. 卵圓孔未閉與慢性阻塞性肺疾病患者缺氧. Chinese Journal of Respiratory and Critical Care Medicine, 2022, 21(5): 305-308. doi: 10.7507/1671-6205.202204068 Copy

1.	Mulvagh SL, DeMaria AN, Feinsten SB, et al. Constrast echocardiography: Current and future application. J Am Soc Echocardiogr, 2000, 13(4): 331-342.
2.	蔡如升, 羅秉坤. 肺動脈高壓//朱貴卿. 呼吸內科學. 北京: 人民衛生出版社, 1984, 390-396.
3.	Rigatelli G, Dell'Avvocata F, Cardaioli P, et al. Permanent right-to-left shunt is the key factor in managing patent foramen ovale. J Am Coll Cardiol, 2011, 58(21): 2257-2261.
4.	Schwerzmann M, Seiler C, Lipp E, et al. Relation between directly detected patent foramen ovale and ischemic brain lesions in sport divers. Ann Intern Med, 2001, 134(1): 21-24.
5.	Allemann Y, Hutter D, Lipp E, et al. Patent foramen ovale and high-altitude pulmonary edema. JAMA, 2006, 296(24): 2954-2258.
6.	Soliman OI, Geleijnse ML, Meijboom FJ, et al. The use of contrast echocardiography for the detection of cardiac shunts. Eur J Echocardiogr, 2007, 8(3): S2-S12.
7.	Wahl A, Jüni P, Mono ML, et al. Long term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paroxysmal embolism. Circulation, 2012, 125(6): 803-812.
8.	Lau EM, Jaijee SK, Melehan KL, et al. Prevalence of patent foramen ovale and its impact on oxygen desaturation in obstructive sleep apnea. Int Cardiol, 2013, 165(1): 35-40.
9.	Soliman A, Shanoudy H, Liu J, et al. Increased prevalence of patent foramen ovale in patients with severe chronic obstructive pulmonary disease. J Am Soc Echocardiogr, 1999, 12(2): 99-105.
10.	Hacievliyagil SS, Gunen H, Kosar FM, et al. Prevalence and clinical significance of a patent foramen ovale in patients with chronic obstructive pulmonary disease. Respir Med, 2006, 100(5): 903-910.
11.	Kilic H, Balci MM, Aksoy MN, et al. Patent foramen ovale among patients with mild chronic obstructive pulmonary disease and unexplained hypoxia. Echocardiography, 2010, 27(6): 687-690.
12.	Martolini D, Tanner R, Davey C, et al. Significance of patent foramen ovale in patients with GOLD stage II chronic obstructive pulmonary disease (COPD). Chronic Obstr Pulm Dis, 2014, 1(2): 185-192.
13.	Shaikh ZF, Kelly JL, Shrikrishna D, et al. Patent foramen ovale is not associated with hypoxemia in severe chronic obstructive pulmonary disease and does not impair exercise performance. Am J Respir Crit Care Med, 2014, 189(5): 540-547.
14.	Rimoldi SF, Ott S, Rexhaj E, et al. Patent foramen ovale closure in obstructive sleep apnea improves blood pressure and cardiovascular function. Hypertension, 2015, 66(5): 1050-1057.
15.	Devendra GP, Rane AA, Krasuski RA. Provoked exercise desaturation in patent foramen ovale and impact of percutaneous closure. JACC Cardiovasc Interv, 2012, 5(4): 416-419.
16.	何權瀛. 慢性阻塞性肺疾病何權瀛 2019 觀點. 北京: 科學技術文獻出版社, 2019, 6.
17.	Naeije R. Pulmonary hypertension and right heart failure in chronic obstructive pulmonary disease. Proc Am Thorac Soc, 2005, 2(1): 20-22.
18.	Scharf SM, Iqbal M, Keller C, et al. National Emphysema Treatment Trial (NETT) Group. Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med, 2002, 166(3): 314-322.
19.	Shawon MS, Perret JL, Senaratna CV, et al. Current evidence on prevalence and clinical outcomes of co-morbid obstructive sleep apnea and chronic obstructive pulmonary disease: a systematic review. Sleep Med Rev, 2017, 32: 58-68.
20.	Shanoudy H, Soliman A, Raggi P, et al. Prevalence of patent foramen ovale and its contruibution to hypoxemia in patients with obstructive sleep apnea. Chest, 1998, 113(1): 91-96.
21.	Beelke M, Angeli S, Sette MD, et al. Prevalence of patent foramen ovale in subjects with obstructive sleep apnea: a transcranial Doppler ultrasound study. Sleep Med, 2003, 4(3): 219-223.
22.	Guchlerner M, Kardos P, Liss-Koch E, et al. PFO and right-to-left shunting in patients with obstructive sleep apnea. J Clin Sleep Med, 2012, 8(4): 375-380.
23.	Kesseler R, Chaouat A, Weitezmblum E, et al. Pulmonary hypertension in the obstructive sleep apnea syndrome: prevalence, cause, and consequences. Eur Respir J, 1996, 9(4): 787-794.
24.	Saikov D, Wang T, Saunders NA, et al. Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am J Respir Crit Care Med, 2002, 165(2): 152-158.
25.	Pinet C, Orehek J. CPAP suppression of awake right to left shunting through patent foramen ovale in a patient with obstructive sleep apnoea. Thorax, 2005, 60(10): 880-881.
26.	Spencer MP, Moehring MA, Jesurum J, et al. Power m-mode transcranial Doppler for diagnosis of patent foramen ovale and assessing transcatheter closure. J Neuroimaging, 2004, 14(4): 342-349.

1. Mulvagh SL, DeMaria AN, Feinsten SB, et al. Constrast echocardiography: Current and future application. J Am Soc Echocardiogr, 2000, 13(4): 331-342.
2. 蔡如升, 羅秉坤. 肺動脈高壓//朱貴卿. 呼吸內科學. 北京: 人民衛生出版社, 1984, 390-396.
3. Rigatelli G, Dell'Avvocata F, Cardaioli P, et al. Permanent right-to-left shunt is the key factor in managing patent foramen ovale. J Am Coll Cardiol, 2011, 58(21): 2257-2261.
4. Schwerzmann M, Seiler C, Lipp E, et al. Relation between directly detected patent foramen ovale and ischemic brain lesions in sport divers. Ann Intern Med, 2001, 134(1): 21-24.
5. Allemann Y, Hutter D, Lipp E, et al. Patent foramen ovale and high-altitude pulmonary edema. JAMA, 2006, 296(24): 2954-2258.
6. Soliman OI, Geleijnse ML, Meijboom FJ, et al. The use of contrast echocardiography for the detection of cardiac shunts. Eur J Echocardiogr, 2007, 8(3): S2-S12.
7. Wahl A, Jüni P, Mono ML, et al. Long term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paroxysmal embolism. Circulation, 2012, 125(6): 803-812.
8. Lau EM, Jaijee SK, Melehan KL, et al. Prevalence of patent foramen ovale and its impact on oxygen desaturation in obstructive sleep apnea. Int Cardiol, 2013, 165(1): 35-40.
9. Soliman A, Shanoudy H, Liu J, et al. Increased prevalence of patent foramen ovale in patients with severe chronic obstructive pulmonary disease. J Am Soc Echocardiogr, 1999, 12(2): 99-105.
10. Hacievliyagil SS, Gunen H, Kosar FM, et al. Prevalence and clinical significance of a patent foramen ovale in patients with chronic obstructive pulmonary disease. Respir Med, 2006, 100(5): 903-910.
11. Kilic H, Balci MM, Aksoy MN, et al. Patent foramen ovale among patients with mild chronic obstructive pulmonary disease and unexplained hypoxia. Echocardiography, 2010, 27(6): 687-690.
12. Martolini D, Tanner R, Davey C, et al. Significance of patent foramen ovale in patients with GOLD stage II chronic obstructive pulmonary disease (COPD). Chronic Obstr Pulm Dis, 2014, 1(2): 185-192.
13. Shaikh ZF, Kelly JL, Shrikrishna D, et al. Patent foramen ovale is not associated with hypoxemia in severe chronic obstructive pulmonary disease and does not impair exercise performance. Am J Respir Crit Care Med, 2014, 189(5): 540-547.
14. Rimoldi SF, Ott S, Rexhaj E, et al. Patent foramen ovale closure in obstructive sleep apnea improves blood pressure and cardiovascular function. Hypertension, 2015, 66(5): 1050-1057.
15. Devendra GP, Rane AA, Krasuski RA. Provoked exercise desaturation in patent foramen ovale and impact of percutaneous closure. JACC Cardiovasc Interv, 2012, 5(4): 416-419.
16. 何權瀛. 慢性阻塞性肺疾病何權瀛 2019 觀點. 北京: 科學技術文獻出版社, 2019, 6.
17. Naeije R. Pulmonary hypertension and right heart failure in chronic obstructive pulmonary disease. Proc Am Thorac Soc, 2005, 2(1): 20-22.
18. Scharf SM, Iqbal M, Keller C, et al. National Emphysema Treatment Trial (NETT) Group. Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med, 2002, 166(3): 314-322.
19. Shawon MS, Perret JL, Senaratna CV, et al. Current evidence on prevalence and clinical outcomes of co-morbid obstructive sleep apnea and chronic obstructive pulmonary disease: a systematic review. Sleep Med Rev, 2017, 32: 58-68.
20. Shanoudy H, Soliman A, Raggi P, et al. Prevalence of patent foramen ovale and its contruibution to hypoxemia in patients with obstructive sleep apnea. Chest, 1998, 113(1): 91-96.
21. Beelke M, Angeli S, Sette MD, et al. Prevalence of patent foramen ovale in subjects with obstructive sleep apnea: a transcranial Doppler ultrasound study. Sleep Med, 2003, 4(3): 219-223.
22. Guchlerner M, Kardos P, Liss-Koch E, et al. PFO and right-to-left shunting in patients with obstructive sleep apnea. J Clin Sleep Med, 2012, 8(4): 375-380.
23. Kesseler R, Chaouat A, Weitezmblum E, et al. Pulmonary hypertension in the obstructive sleep apnea syndrome: prevalence, cause, and consequences. Eur Respir J, 1996, 9(4): 787-794.
24. Saikov D, Wang T, Saunders NA, et al. Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am J Respir Crit Care Med, 2002, 165(2): 152-158.
25. Pinet C, Orehek J. CPAP suppression of awake right to left shunting through patent foramen ovale in a patient with obstructive sleep apnoea. Thorax, 2005, 60(10): 880-881.
26. Spencer MP, Moehring MA, Jesurum J, et al. Power m-mode transcranial Doppler for diagnosis of patent foramen ovale and assessing transcatheter closure. J Neuroimaging, 2004, 14(4): 342-349.

Next Article
Analysis of pulmonary function test and medication treatment of patients with chronic obstructive pulmonary disease aged 40 years or older in community of Guangdong Province

Chinese Journal of Respiratory and Critical Care Medicine

卵圓孔未閉與慢性阻塞性肺疾病患者缺氧

Abstract Full text Figures/Tables Video References Cited by

Next Article

Format

Content